Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 33.00
Ask: 35.00
Change: -0.50 (-1.45%)
Spread: 2.00 (6.061%)
Open: 34.50
High: 34.50
Low: 34.00
Prev. Close: 34.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: YouGov, Sareum and InterQuest...

Tue, 07th Aug 2012 11:25

Environmental Recycling Technologies, which owns the rights to the Powder Impression Moulding (PIM) process which is capable of converting mixed waste plastics into commercially viable products, has confirmed that its US parent application, entitled 'Process for Forming Plastic, Apparatuses for Forming Plastic and Articles Made Therefrom', has been granted by the US Patent Office. This is ERT's core patent in the US for the PIM process. Sareum, a specialist cancer drug discovery business, has said it notes the recent significant rise in its share price and has confirmed that "advanced stages of negotiations are taking place with a potential licencing partner". It added these "may or may not lead to a licencing agreement regarding one of the company's research programmes". Shares were up 184% on Tuesday, equal to 1.15p. The stock has gained 42% over the past year, and 163% in the past month. YouGov, the online market research firm, is anticipating that its operating profit will be in line with expectations with second half revenue similar to that achieved in the first half, reflecting the firm's focus on profitability in the German business and the expected end to a long-term contract in Iraq. The firm said its balance sheet remains strong with cash at July 31st of around £7.0m. TClarke, a building services company, reported a decline in pre-tax profit for the half year at £0.5m (2011: £1.4m) on revenues of £90.7m (2011: £92.6m), with the profit margin also lower at 0.5% compared to 1.5% the previous year. Basic earnings per share dropped from 2.38p to 0.79p, while net cash climbed £0.1m to £0.7m. The interim dividend was maintained at 1p per share. The firm blamed a lack of confidence across the sector for the declines and said that with a number of projects due to begin shortly it is confident of significant revenue progress in the second half. Shares in InterQuest Group, a specialist information technology recruitment group, took a hit after it admitted earnings before interest, tax, depreciation and amortisation are expected to be down year-on-year, in the region of £1.15m (2011: £1.86m), and warned the impact of investments and restructuring on profitability for 2012 will be around £1.6m. Trading conditions were poor in both the UK and Far East, particularly in the second quarter and particularly in the banking and finance sectors from which it derives 27% of its net fee income. This has meant profitability from investments has taken longer than anticipated. NR
More News
7 Jun 2012 13:59

Small caps round-up: Cyan, Aer Lingus, Mobile Tornado ...

Cyan Holdings, the wireless solutions company, has revealed that three more Cyan partners have received requests from the Tamil Nadu Electricity Board (TNEB) Automatic Meter Reading tender to proceed with installation and commissioning of 500 unit pilots within the next 25 days. The news follows Cya

Read more
6 Jun 2012 14:22

Small caps round-up: PLUS Markets, Sareum, Planet Payment

PLUS Markets Group, which provides listing and quoting services to around 140 companies on the stock exchange, has recommended its shareholders to vote in favour of the proposed disposal of its PLUS-SX division to ICAP for a nominal sum at its general meeting on June 18th. 'The disposal will, theref

Read more
27 Feb 2012 14:57

Sareum confident of at least one deal in 2012

Penny stock Sareum, which develops drugs to combat cancer, saw its losses widen in the second half of 2011, in line with the board's expectations. The firm's losses after tax deepened from £0.26m to £0.33m, which the firm said reflects an increase in research and development. Pre-tax losses totall

Read more
15 Aug 2011 11:50

Cancer results boost Sareum

Cancer drug discovery business Sareum shot ahead after it said it had selected a "preclinical development candidate" from research into Chk1, a method of controlling a cancer cells' response to DNA damage. The candidate, when orally dosed, reduces cancer growth rates compared to treatment with the

Read more
4 Mar 2011 11:08

Sareum soars after colon cancer study

Shares in Sareum were soaring after the cancer drug discovery business announced positive results from a study into colon cancer. The study, which was conducted by the Institute of Cancer Research, founded that Sareum's Chk1 inhibitor, used alongside a gemcitabine, a chemotherapeutic, "demonstrate

Read more
21 Feb 2011 15:56

Sareum narrows losses

Sareum, the cancer drug discovery business that earlier this month shot up after announcing positive results from a leukaemia study, narrowed losses in the half year to 31 December. Pre-tax losses narrowed to £281,000 from £321,000 over the same period a year ago. "Recent fundraisings provide us w

Read more
7 Feb 2011 11:52

Small caps round-up: Henry Boot, Firestone Diamonds, Amino Tech...

Property developer Henry Boot says it will move to a net cash position after it agreed the sale of a shopping centre in Ayr for £33.8m and the sale of land with planning permission to build houses in Buckingham for an undisclosed fee. Henry Boot said last month that one of its goals is to 'manage d

Read more
16 Mar 2010 10:50

Small caps round-up: Amphion, Bioquell, Ablon...

Shares in Amphion Innovations jumped after the medical and technology sector said it was cautious but confident in the strength of its model following a year which saw revenue increase to $8.6m from $7.1m in 2008, but losses increase to $2.9m from $1.8m. Shares in Bioquell moved in the other direct

Read more
20 Jan 2010 13:10

Small caps round-up: ING Real, Intellego, Oxford Intruments...

ING UK Real Estate Income Trust will repay £15m of debt through the purchase and cancellation of loan notes at a discount to nominal value in two separate transactions. The transaction will result in a one off gain to NAV expected to be in the order of £680,000, and will also save over £719,000 per

Read more
27 Oct 2009 11:09

Small caps round-up: Ariana, Gemfields, Sareum

Turkey-focused gold miner Ariana Resources has set up a 50:50 joint venture to combine its two main projects, Sindirgi and Tavsan, into a single conceptual entity. The company confirmed its partner in the 'Red Rabbit' project as Turkish turn-key construction firm Proccea Construction. "A Memorandu

Read more
6 Oct 2009 09:47

Small caps round-up: ProStrakan, Sareum,Sirius

Speciality pharmaceutical company ProStrakan's New Drug Application (NDA) filing for Abstral has been accepted for review by the US Food and Drug Administration (FDA). Subject to successful completion of the US approval process, the Scottish firm plans to launch Abstral, which helps ease pain for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.